2025 fourth_quarter Filing
Q4Income
$25K
Filed
January 28, 2026
Lobbying Activities
Health IssuesView all
Development of Amicidins to serve as a countermeasure/therapeutic intervention for Sepsis, field care for MCM in burn/blast/chem, and altering the future of packaging.
Contacted:Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (1)
DANIEL FARACI